Summary

The global market for Human Serum Albumin was estimated to be worth US$ 6375 million in 2024 and is forecast to a readjusted size of US$ 9817 million by 2031 with a CAGR of 6.5% during the forecast period 2025-2031.
Human Serum Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
The human serum albumin (HSA) market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, HSA is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.
However, the market faces challenges such as limited plasma supply and high production costs, as HSA is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant HSA (rHSA) is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global HSA market.
The key global producers of human serum albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrio, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.
This report aims to provide a comprehensive presentation of the global market for Human Serum Albumin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Serum Albumin by region & country, by Type, and by Application.
The Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Serum Albumin.
Market Segmentation
By Company
Grifols
CSL
Takeda
Octapharma
CBPO
Hualan Bio
Kedrion
Shanghai RAAS
LFB Group
Weiguang Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Segment by Type
20-25% Concentrations
5% Concentrations
Segment by Application
Therapeutics
Excipient
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Serum Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Serum Albumin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Human Serum Albumin Product Introduction
1.2 Global Human Serum Albumin Market Size Forecast
1.2.1 Global Human Serum Albumin Sales Value (2020-2031)
1.2.2 Global Human Serum Albumin Sales Volume (2020-2031)
1.2.3 Global Human Serum Albumin Sales Price (2020-2031)
1.3 Human Serum Albumin Market Trends & Drivers
1.3.1 Human Serum Albumin Industry Trends
1.3.2 Human Serum Albumin Market Drivers & Opportunity
1.3.3 Human Serum Albumin Market Challenges
1.3.4 Human Serum Albumin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Serum Albumin Players Revenue Ranking (2024)
2.2 Global Human Serum Albumin Revenue by Company (2020-2025)
2.3 Global Human Serum Albumin Players Sales Volume Ranking (2024)
2.4 Global Human Serum Albumin Sales Volume by Company Players (2020-2025)
2.5 Global Human Serum Albumin Average Price by Company (2020-2025)
2.6 Key Manufacturers Human Serum Albumin Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Serum Albumin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Human Serum Albumin
2.9 Human Serum Albumin Market Competitive Analysis
2.9.1 Human Serum Albumin Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Serum Albumin Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Serum Albumin as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 20-25% Concentrations
3.1.2 5% Concentrations
3.2 Global Human Serum Albumin Sales Value by Type
3.2.1 Global Human Serum Albumin Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Human Serum Albumin Sales Value, by Type (2020-2031)
3.2.3 Global Human Serum Albumin Sales Value, by Type (%) (2020-2031)
3.3 Global Human Serum Albumin Sales Volume by Type
3.3.1 Global Human Serum Albumin Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Human Serum Albumin Sales Volume, by Type (2020-2031)
3.3.3 Global Human Serum Albumin Sales Volume, by Type (%) (2020-2031)
3.4 Global Human Serum Albumin Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Therapeutics
4.1.2 Excipient
4.1.3 Other
4.2 Global Human Serum Albumin Sales Value by Application
4.2.1 Global Human Serum Albumin Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Human Serum Albumin Sales Value, by Application (2020-2031)
4.2.3 Global Human Serum Albumin Sales Value, by Application (%) (2020-2031)
4.3 Global Human Serum Albumin Sales Volume by Application
4.3.1 Global Human Serum Albumin Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Human Serum Albumin Sales Volume, by Application (2020-2031)
4.3.3 Global Human Serum Albumin Sales Volume, by Application (%) (2020-2031)
4.4 Global Human Serum Albumin Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Human Serum Albumin Sales Value by Region
5.1.1 Global Human Serum Albumin Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Human Serum Albumin Sales Value by Region (2020-2025)
5.1.3 Global Human Serum Albumin Sales Value by Region (2026-2031)
5.1.4 Global Human Serum Albumin Sales Value by Region (%), (2020-2031)
5.2 Global Human Serum Albumin Sales Volume by Region
5.2.1 Global Human Serum Albumin Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Human Serum Albumin Sales Volume by Region (2020-2025)
5.2.3 Global Human Serum Albumin Sales Volume by Region (2026-2031)
5.2.4 Global Human Serum Albumin Sales Volume by Region (%), (2020-2031)
5.3 Global Human Serum Albumin Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Human Serum Albumin Sales Value, 2020-2031
5.4.2 North America Human Serum Albumin Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Human Serum Albumin Sales Value, 2020-2031
5.5.2 Europe Human Serum Albumin Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Human Serum Albumin Sales Value, 2020-2031
5.6.2 Asia Pacific Human Serum Albumin Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Human Serum Albumin Sales Value, 2020-2031
5.7.2 South America Human Serum Albumin Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Serum Albumin Sales Value, 2020-2031
5.8.2 Middle East & Africa Human Serum Albumin Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Serum Albumin Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Human Serum Albumin Sales Value and Sales Volume
6.2.1 Key Countries/Regions Human Serum Albumin Sales Value, 2020-2031
6.2.2 Key Countries/Regions Human Serum Albumin Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Human Serum Albumin Sales Value, 2020-2031
6.3.2 United States Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Human Serum Albumin Sales Value, 2020-2031
6.4.2 Europe Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Human Serum Albumin Sales Value, 2020-2031
6.5.2 China Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.5.3 China Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Human Serum Albumin Sales Value, 2020-2031
6.6.2 Japan Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Human Serum Albumin Sales Value, 2020-2031
6.7.2 South Korea Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Human Serum Albumin Sales Value, 2020-2031
6.8.2 Southeast Asia Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Human Serum Albumin Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Human Serum Albumin Sales Value, 2020-2031
6.9.2 India Human Serum Albumin Sales Value by Type (%), 2024 VS 2031
6.9.3 India Human Serum Albumin Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Grifols
7.1.1 Grifols Company Information
7.1.2 Grifols Introduction and Business Overview
7.1.3 Grifols Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Grifols Human Serum Albumin Product Offerings
7.1.5 Grifols Recent Development
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 CSL Human Serum Albumin Product Offerings
7.2.5 CSL Recent Development
7.3 Takeda
7.3.1 Takeda Company Information
7.3.2 Takeda Introduction and Business Overview
7.3.3 Takeda Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Takeda Human Serum Albumin Product Offerings
7.3.5 Takeda Recent Development
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Octapharma Human Serum Albumin Product Offerings
7.4.5 Octapharma Recent Development
7.5 CBPO
7.5.1 CBPO Company Information
7.5.2 CBPO Introduction and Business Overview
7.5.3 CBPO Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 CBPO Human Serum Albumin Product Offerings
7.5.5 CBPO Recent Development
7.6 Hualan Bio
7.6.1 Hualan Bio Company Information
7.6.2 Hualan Bio Introduction and Business Overview
7.6.3 Hualan Bio Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Hualan Bio Human Serum Albumin Product Offerings
7.6.5 Hualan Bio Recent Development
7.7 Kedrion
7.7.1 Kedrion Company Information
7.7.2 Kedrion Introduction and Business Overview
7.7.3 Kedrion Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Kedrion Human Serum Albumin Product Offerings
7.7.5 Kedrion Recent Development
7.8 Shanghai RAAS
7.8.1 Shanghai RAAS Company Information
7.8.2 Shanghai RAAS Introduction and Business Overview
7.8.3 Shanghai RAAS Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Shanghai RAAS Human Serum Albumin Product Offerings
7.8.5 Shanghai RAAS Recent Development
7.9 LFB Group
7.9.1 LFB Group Company Information
7.9.2 LFB Group Introduction and Business Overview
7.9.3 LFB Group Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 LFB Group Human Serum Albumin Product Offerings
7.9.5 LFB Group Recent Development
7.10 Weiguang Bio
7.10.1 Weiguang Bio Company Information
7.10.2 Weiguang Bio Introduction and Business Overview
7.10.3 Weiguang Bio Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Weiguang Bio Human Serum Albumin Product Offerings
7.10.5 Weiguang Bio Recent Development
7.11 Tiantan Bio
7.11.1 Tiantan Bio Company Information
7.11.2 Tiantan Bio Introduction and Business Overview
7.11.3 Tiantan Bio Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Tiantan Bio Human Serum Albumin Product Offerings
7.11.5 Tiantan Bio Recent Development
7.12 Shuanglin Bio
7.12.1 Shuanglin Bio Company Information
7.12.2 Shuanglin Bio Introduction and Business Overview
7.12.3 Shuanglin Bio Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Shuanglin Bio Human Serum Albumin Product Offerings
7.12.5 Shuanglin Bio Recent Development
7.13 Boya Bio
7.13.1 Boya Bio Company Information
7.13.2 Boya Bio Introduction and Business Overview
7.13.3 Boya Bio Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Boya Bio Human Serum Albumin Product Offerings
7.13.5 Boya Bio Recent Development
7.14 Yuanda Shuyang
7.14.1 Yuanda Shuyang Company Information
7.14.2 Yuanda Shuyang Introduction and Business Overview
7.14.3 Yuanda Shuyang Human Serum Albumin Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 Yuanda Shuyang Human Serum Albumin Product Offerings
7.14.5 Yuanda Shuyang Recent Development
8 Industry Chain Analysis
8.1 Human Serum Albumin Industrial Chain
8.2 Human Serum Albumin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Human Serum Albumin Sales Model
8.5.2 Sales Channel
8.5.3 Human Serum Albumin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer